Skip to content

Evaluation of a national quality improvement program to overcome barriers to using performance data in intensive care medicine

Evaluation of a national quality improvement program to overcome barriers to using performance data in intensive care medicine: A cluster randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN50542146
Enrollment
30
Registered
2010-11-01
Start date
2009-01-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality improvement in intensive care medicine Not Applicable

Interventions

Intensive care units participating in InFoQI establish a local multidisciplinary quality improvement team, consisting of at least one intensivist and one ICU nurse. The team's main tasks are to formul

Sponsors

Academic Medical Centre (AMC) (Netherlands)
Lead Sponsor
University of Tilburg
Collaborator
NICE Foundation
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Intensive Care Units that are able to provide their performance data to the national comparative quality registry on intensive care medicine in the Netherlands (NICE registry) and have at least one intensivist and one ICU nurse available for a minimum of four hours per month each. Informed consent was signed by the ICU management before randomisation.

Exclusion criteria

Exclusion criteria: Intensive Care Units that did not meet the inclusion criteria

Design outcomes

Primary

MeasureTime frame
1. Clinical: ICU length of stay 2. Non-clinical: Proportion of shifts with a bed occupancy of 100% or more

Secondary

MeasureTime frame
1. Clinical: 1.1. Hospital mortality of ICU patients 1.2. Respiration duration 2. Non-clinical: Proportion of shifts with a nurse-to-patient ratio below 0.5

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 28, 2026